Similar drugsTo uncover
Dosage form: & nbspPowder for solution for oral administration
Composition:

Per one packing:

Active components:

Althea roots extract dry (semifinished) with the amount of reducing monosaccharides in terms of glucose 4.0%

0.300 grams

Licorice extract is dry with glycyrrhizic acid content in terms of monoammonium salt of glycyrrhizic acid hydrate and absolutely dry substance 17.0%

0.075 g

Sodium bicarbonate

0.150 g

Excipients:

Sugar (sucrose)

0.7500 g

Sodium benzoate

0.1500 g

Ammonium chloride

0.0375 g

Anise oil

0.0037 g

Powder weight in packing

1.47 g

Description:Inhomogeneous powder mixture from grayish brown to brownish-gray with a pinkish hue of color with lighter and darker impregnations with a weak characteristic odor. During storage, it is allowed to clump. The aqueous solution of the preparation (1:10) should be brown.
Pharmacotherapeutic group:Expectorant of plant origin
ATX: & nbsp
  • Combination of expectorants
  • Pharmacodynamics:

    Combined drug.

    Has expectorant and anti-inflammatory effect.

    Althea roots extract dry strengthens the secretion of bronchial glands; licorice extract has an anti-inflammatory,expectorant and spasmolytic action.

    Sodium bicarbonate shifts the pH of bronchial mucus to the alkaline side, reduces the viscosity of sputum; sodium benzoate and ammonium chloride have an expectorant effect.

    Pharmacokinetics:No data available.
    Indications:

    As an expectorant for diseases of the respiratory tract, accompanied by a cough with hard-to-separate sputum (including tracheitis, bronchitis, bronchopneumonia).

    Contraindications:

    Hypersensitivity to the drug components, acute glomerulonephritis, acute pyelonephritis.

    Congenital intolerance of fructose, glucose-galactose malabsorption, deficiency of sugar / isomaltase.

    If you have any of these diseases, consult a doctor before taking the drug.

    Carefully:

    Patients with diabetes and people on a diet with a low carbohydrate content and low sodium content.

    If you have any of these diseases, consult a doctor before taking the drug.

    Pregnancy and lactation:

    It is not recommended for pregnancy and breastfeeding because of the lack of special studies.

    Dosing and Administration:

    Inside, in the form of a solution 3-4 times a day after meals.

    To prepare the solution, the contents of the packet (1.47 g) are dissolved in 1 tablespoon (15 ml) of cooled boiled water. The shelf life of the solution in the refrigerator is no more than 2 days. Shake before use.

    The drug is administered to children according to age:

    up to 1 year - 15-20 drops;

    from 1 year to 2 years - 40 drops each;

    from 3 to 4 years - by 1/2 a teaspoonful (2.5 ml);

    from 5 before 6 years - by 2/3 a teaspoonful (3,75 ml);

    from 7 to 8 years - 1 teaspoonful (5 ml);

    from 9 to 12 years - 2 teaspoons (10 ml);

    over 12 years old - 1 tablespoon (15 ml).

    The course of treatment is from 14 to 20 days. Conducting repeated courses of treatment is possible after consultation with a doctor.

    Side effects:

    There may be allergic reactions, nausea, vomiting, diarrhea; can have irritating effect on the mucous membrane of the stomach. In these cases, the drug should be discontinued.

    If any of the side effects listed in the manual are aggravated, or if you notice any other side effects not listed in the instructions, inform the doctor about it.

    Overdose:

    To date, no cases of overdose have been observed.

    Interaction:

    It is not recommended to apply simultaneously with antitussive drugs, as well as with drugs that reduce the formation of sputum.

    Special instructions:

    Patients with diabetes should take into account that in 1 drop of the drug solution contains about 0.0025 grams (0.0002 XE) of carbohydrates, in 1 ml of the drug solution - about 0.05 g (0.004 kg) of carbohydrates, in 1 teaspoon of the drug solution - about 0.25 g (0.021 XE); in 1 tablespoon of the drug solution - about 0,75 g (0,0625 ХЕ).

    Effect on the ability to drive transp. cf. and fur:

    The drug has no effect on the ability to perform potentially hazardous activities requiring increased concentration of attention and speed of psychomotor reactions (including driving, working with moving mechanisms).

    Form release / dosage:

    Powder for solution for oral administration.

    Packaging:

    By 1.47 g in packages heat-sealing from paper with a polyethylene coating or from laminated paper, or from a composite material. 10 or 25 bags, together with instructions for use, are placed in a pack of cardboard. It is allowed to pack the packages together with an equal number of instructions for use in a box or in a cardboard box (for hospitals).

    Storage conditions:

    In a dry place at a temperature of no higher than 25 ° C.

    Keep out of the reach of children.

    Shelf life:

    1 year 6 months

    Do not use after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LP-002153
    Date of registration:19.07.2013 / 07.05.2014
    Expiration Date:19.07.2018
    The owner of the registration certificate:VIFITEH, CJSC VIFITEH, CJSC Russia
    Manufacturer: & nbsp
    Representation: & nbspVIFITEH, CJSCVIFITEH, CJSC
    Information update date: & nbsp09.06.2018
    Illustrated instructions
      Instructions
      Up